Tag: Pharma
MaaT Pharma publishes its annual results for the year 2023 and provides an update on its activities – 03/28/2024 at 6:15 p.m.
MaaT Pharma (EURONEXT: MAAT – the “Company”), an advanced clinical stage biotechnology company, leader in the development of Microbiome Ecosystem TherapiesTM (MET) aimed at improving the survival of cancer patients,…
MaaT Pharma strengthens its management team
(AOF) – MaaT Pharma, a late clinical stage biotechnology company, announces the appointment of Jonathan Chriqui, PharmD, to the position of chief business officer and member of the management team.…
Innate Pharma: cash horizon extends until end of 2025
(AOF) – On the occasion of the presentation of its 2023 results, Innate Pharma specifies that its cash position was 102.3 million euros as of December 31, 2023 – this…
ABIONYX Pharma – Bpifrance supports the development of CER-001 in ophthalmology with non-dilutive innovation aid of around 1 million euros – 03/14/2024 at 6:00 p.m.
• Validation of the development of CER-001 in ophthalmology• Key step to launch a clinical study in a new severe indication Toulouse, FRANCE, Lakeland, UNITED STATES, March 14, 2024, 6:00…
AstraZeneca buys French biotech Amolyt Pharma for near-record sum of $1 billion
In the history of French biotech, Amolyt Pharma will undoubtedly feature prominently in the pantheon of French successes. The company, based in Ecully, in the Lyon metropolis, has just announced,…
Abionyx Pharma: will benefit from aid from 1ME from Bpifrance
(CercleFinance.com) – Abionyx Pharma announces innovation aid of nearly 1 million euros from Bpifrance. The purpose of this aid is to support the drug candidate CER-001 dedicated to the treatment…
Abionyx Pharma receives nearly 1 million euros from Bpifrance
(AOF) – Abionyx Pharma announces that it is the beneficiary of innovation aid of nearly 1 million euros from Bpifrance. The biotech specialist in innovative therapies based on the only…
Abionyx Pharma: will benefit from 1ME aid from Bpifrance – 03/14/2024 at 6:20 p.m.
Member Login Customer Login (CercleFinance.com) – Abionyx Pharma announces innovation aid of nearly 1 million euros from Bpifrance. The purpose of this aid is to support the drug candidate CER-001…
Abionyx Pharma receives nearly 1 million euros from Bpifrance – 03/14/2024 at 6:21 p.m.
(AOF) – Abionyx Pharma announces that it is the beneficiary of innovation aid of nearly 1 million euros from Bpifrance. The biotech specialist in innovative therapies based on the only…
ABIONYX Pharma announces its 2023 annual results – 03/11/2024 at 07:30
• 20% reduction in annual operational loss • Cash of €4.1 million as of December 31, 2023 Toulouse, FRANCE, Lakeland, UNITED STATES, March 11, 2024, 7:30 a.m. CET – ABIONYX…
Abionyx Pharma: 2024 financial agenda
A.S. Published on 03/10/2024 at 5:31 p.m. Photo credit © Abionyx Pharma (Boursier.com) — Abionyx…
ABIONYX Pharma announces its financial communication calendar for the 2024 financial year – 03/07/2024 at 7:00 p.m.
Toulouse, FRANCE, Lakeland, UNITED STATES, March 7, 2024, 7:00 p.m. – ABIONYX Pharma, (FR0012616852 – ABNX – PEA PME eligible), new generation biotechnology company dedicated to the discovery and development…